Editorial & Columns
#Dr.AnilKumarAngrish Archive
Editorial & Columns
Insider or an Outsider as a CEO: Insights on Pharmaceutical Industry in India
Editorial & Columns
On the Right Side of Regulations: The USFDA and Indian Pharmaceutical Companies
Editorial & Columns
CSR by Pharmaceutical Companies and Engagement with SHGs, NGOs & Foundations
Editorial & Columns
Patent Cliff: Opportunity for Indian Pharmaceutical Companies
Editorial & Columns
Trump, Tariffs and Trade of Pharmaceuticals from India
Editorial & Columns
Make in India: PLI for Pharmaceutical Industry
Editorial & Columns
Union Budget 2025: Impact on Pharmaceutical Sector
Editorial & Columns
Trump, PEPFAR and Indian Pharmaceutical Industry
Editorial & Columns